¼¼°èÀÇ ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼­ºñ½º ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, ½ÃÇè À¯Çüº°, Á¦Ç° À¯Çüº°, °³¹ß ´Ü°èº°, ÀûÀÀÁõº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Cell & Gene Therapy Bioanalytical Testing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By Product Type, By Stage of Development, By Indication, By Region and Competition, 2020-2030F
»óǰÄÚµå : 1732824
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 182 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,197,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,574,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,017,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼­ºñ½º ½ÃÀåÀº 2024³â¿¡´Â 5¾ï 2,326¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2030³â¿¡´Â 8¾ï 7,029¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ Áß CAGRÀº 8.85%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ºÐ¾ßÀÇ È®ÀåÀº °³ÀÎ ¸ÂÃãÇü Ç¥Àû Ä¡·á¹ýÀ» Á¦°øÇÔÀ¸·Î½á À¯Àü ¹× ¸¸¼º Áúȯ¿¡ ´ëÇÑ Ä¡·á Á¢±Ù¹ýÀ» Çõ½ÅÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ä¡·á¹ýÀÌ ¿¬±¸ ´Ü°è¿¡¼­ »ó¿ëÈ­·Î ¹ßÀüÇÔ¿¡ µû¶ó Á¤È®ÇÏ°í ±ÔÁ¤À» ÁؼöÇÏ´Â ¹ÙÀÌ¿À ºÐ¼® Å×½ºÆ® ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼­ºñ½º´Â ÁøÈ­ÇÏ´Â ±ÔÁ¦ ±â´ëÄ¡¿¡ ¸ÂÃç ¾ÈÀü¼º, À¯È¿¼º ¹× ǰÁúÀ» º¸ÀåÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. Áö¿ø ÀÚ±Ý, ±â¼ú Çõ½Å, Ä¡·á ÆÄÀÌÇÁ¶óÀÎÀÇ È®´ë·Î ½ÃÀå °³¹ßÀÌ °¡¼ÓÈ­µÇ°í ÀÖÀ¸¸ç, ¸ÂÃãÇü Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¾÷°èÀÇ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¼ö¸í Áֱ⿡¼­ ¹ÙÀÌ¿À ºÐ¼® ½ÃÇèÀÇ ¿ªÇÒÀÌ °è¼Ó ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð(2024³â) 5¾ï 2,326¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð(2030³â) 8¾ï 7,029¸¸ ´Þ·¯
CAGR(2025-2030³â) 8.85%
±Þ¼ºÀå ºÎ¹® Á¾¾çÇÐ
ÃÖ´ë ½ÃÀå ºÏ¹Ì

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¿¬±¸ ¹× °³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡

ÁÖ¿ä ½ÃÀå °úÁ¦

±ÔÁ¦ ¹®Á¦

ÁÖ¿ä ½ÃÀå µ¿Çâ

±â¼ú ¹ßÀü

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¸ñ¼Ò¸®

Á¦5Àå ¼¼°èÀÇ ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼­ºñ½º ½ÃÀå Àü¸Á

Á¦6Àå ºÏ¹ÌÀÇ ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼­ºñ½º ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼­ºñ½º ½ÃÀå Àü¸Á

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼­ºñ½º ½ÃÀå Àü¸Á

Á¦9Àå ³²¹ÌÀÇ ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼­ºñ½º ½ÃÀå Àü¸Á

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼­ºñ½º ½ÃÀå Àü¸Á

Á¦11Àå ½ÃÀå ¿ªÇÐ

Á¦12Àå ½ÃÀå µ¿Çâ ¹× ¹ßÀü

Á¦13Àå ¼¼°èÀÇ ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼­ºñ½º ½ÃÀå :SWOT ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

Á¦15Àå Àü·«Àû Á¦¾È

Á¦16Àå ±â¾÷ ¼Ò°³¿Í ¸éÃ¥»çÇ×

HBR
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Cell & Gene Therapy Bioanalytical Testing Services Market was valued at USD 523.26 million in 2024 and is expected to reach USD 870.29 million by 2030, growing at a CAGR of 8.85% during the forecast period. The expanding field of cell and gene therapy is revolutionizing treatment approaches for genetic and chronic diseases by offering personalized, targeted therapies. As these therapies progress from research to commercialization, the demand for precise and compliant bioanalytical testing services is growing significantly. These services are critical for ensuring safety, efficacy, and quality in line with evolving regulatory expectations. Supportive funding, technological innovations, and the expanding therapeutic pipeline are accelerating market development, while growing industry emphasis on tailored treatment solutions continues to elevate the role of bioanalytical testing in the cell and gene therapy lifecycle.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 523.26 Million
Market Size 2030USD 870.29 Million
CAGR 2025-20308.85%
Fastest Growing SegmentOncology
Largest MarketNorth America

Key Market Drivers

Increasing Investment in Cell and Gene Therapy Research and Development

Recent breakthroughs in cell and gene therapy have opened new possibilities for treating diseases previously deemed untreatable. These treatments work by altering patients' own cells or genes to address conditions such as cancer, autoimmune disorders, and genetic abnormalities. As the clinical potential of these therapies becomes more evident, global investment in research and development has increased rapidly. Bioanalytical testing services play an essential role in this growth by ensuring product safety, efficacy, and consistency. Notably, in April 2023, the California Institute for Regenerative Medicine committed USD 89.0 million toward advancing gene and stem cell research, exemplifying the growing commitment to innovation in this space.

Key Market Challenges

Regulatory Challenges

Navigating regulatory frameworks remains one of the most pressing challenges in the cell and gene therapy bioanalytical testing market. Regulatory agencies are continuously updating standards to ensure patient safety while accommodating rapid technological advances. This dynamic landscape makes compliance a complex and time-consuming process. Companies often face delays and increased costs when attempting to align with these evolving guidelines, which can hinder the pace of therapy development and market entry. Meeting global regulatory expectations while innovating at speed demands significant investment and specialized expertise.

Key Market Trends

Technological Advancements

As cell and gene therapies reshape modern medicine, the bioanalytical testing segment is advancing rapidly to meet new analytical demands. A major trend is the integration of single-cell analysis technologies, including single-cell RNA sequencing and proteomics, which allow deeper insights into cellular responses and therapeutic outcomes. These methods address the limitations of traditional bulk analysis by revealing intercellular variability. Another transformative trend is the adoption of CRISPR-Cas9, a powerful gene-editing tool that demands specialized testing protocols to evaluate gene function and detect potential off-target effects. Furthermore, the deployment of state-of-the-art instrumentation has enhanced the precision and speed of testing processes, enabling faster and more accurate evaluation of complex therapies and supporting the broader growth of the market.

Key Market Players

Report Scope:

In this report, the Global Cell & Gene Therapy Bioanalytical Testing Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type:

Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type:

Cell & Gene Therapy Bioanalytical Testing Services Market, By Stage of Development:

Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication:

Cell & Gene Therapy Bioanalytical Testing Services Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell & Gene Therapy Bioanalytical Testing Services Market.

Available Customizations:

Global Cell & Gene Therapy Bioanalytical Testing Services market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Cell & Gene Therapy Bioanalytical Testing Services Market Outlook

6. North America Cell & Gene Therapy Bioanalytical Testing Services Market Outlook

7. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Outlook

8. Asia-Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Outlook

9. South America Cell & Gene Therapy Bioanalytical Testing Services Market Outlook

10. Middle East and Africa Cell & Gene Therapy Bioanalytical Testing Services Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Global Cell & Gene Therapy Bioanalytical Testing Services Market: SWOT Analysis

14. Competitive Landscape

15. Strategic Recommendations

16. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â